Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Shimada

Showing results (81-90 of 295) with videos related to

Pageof 30
Sort By:
Annals of Surgical Oncology|April 26, 2018
A Novel Physiobiological Parameter-Based Grading System for Resectable Pancreatic CancerTakehiro Okabayashi, Yasuo Shima, Tatsuaki Sumiyoshi, et al.
Japanese Journal of Clinical Oncology|April 25, 2009
A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603Yukihide Kanemitsu, Tomoyuki Kato, Yasuhiro Shimizu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 3, 2007
Possible roles of neuropeptide Y Y3-receptor subtype in rat aortic endothelial cell proliferation under hypoxia, and its specific signal transductionZhi-Yong Chen, Guo-Gang Feng, Kimitoshi Nishiwaki, et al.
Investigational New Drugs|September 7, 2011
Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancerYasuhide Yamada, Tatsuro Yamaguchi, Hiroshi Matsumoto, et al.
International Journal of Clinical Oncology|October 16, 2010
Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake: a retrospective studySatoru Iwasa, Takako Eguchi Nakajima, Kenichi Nakamura, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 17, 2011
First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancerSatoru Iwasa, Takako Eguchi Nakajima, Kenichi Nakamura, et al.
European Journal of Pharmacology|September 24, 2004
A role for L-glutamate ionotropic receptors in the development of rat neurogenic pulmonary edemaHiroko Kondo, Guo-Gang Feng, Kimitoshi Nishiwaki, et al.
Anticancer Research|December 26, 2012
Lack of association of proteinuria and clinical outcome in patients treated with bevacizumab for metastatic colorectal cancerSatoru Iwasa, Takako Eguchi Nakajima, Kengo Nagashima, et al.
Oncology|June 12, 2008
Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancerJunichi Matsubara, Yasuhide Yamada, Takako E Nakajima, et al.
Japanese Journal of Clinical Oncology|April 7, 2011
A Phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical Stage II/III squamous cell carcinoma of anal canal (JCOG0903: SMART-AC)Atsuo Takashima, Yasuhiro Shimada, Tetsuya Hamaguchi, et al.
Pageof 30

Showing results (81-90 of 295) with videos related to

Sort By:
Pageof 30
Annals of Surgical Oncology|April 26, 2018
A Novel Physiobiological Parameter-Based Grading System for Resectable Pancreatic CancerTakehiro Okabayashi, Yasuo Shima, Tatsuaki Sumiyoshi, et al.
Japanese Journal of Clinical Oncology|April 25, 2009
A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603Yukihide Kanemitsu, Tomoyuki Kato, Yasuhiro Shimizu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 3, 2007
Possible roles of neuropeptide Y Y3-receptor subtype in rat aortic endothelial cell proliferation under hypoxia, and its specific signal transductionZhi-Yong Chen, Guo-Gang Feng, Kimitoshi Nishiwaki, et al.
Investigational New Drugs|September 7, 2011
Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancerYasuhide Yamada, Tatsuro Yamaguchi, Hiroshi Matsumoto, et al.
International Journal of Clinical Oncology|October 16, 2010
Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake: a retrospective studySatoru Iwasa, Takako Eguchi Nakajima, Kenichi Nakamura, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 17, 2011
First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancerSatoru Iwasa, Takako Eguchi Nakajima, Kenichi Nakamura, et al.
European Journal of Pharmacology|September 24, 2004
A role for L-glutamate ionotropic receptors in the development of rat neurogenic pulmonary edemaHiroko Kondo, Guo-Gang Feng, Kimitoshi Nishiwaki, et al.
Anticancer Research|December 26, 2012
Lack of association of proteinuria and clinical outcome in patients treated with bevacizumab for metastatic colorectal cancerSatoru Iwasa, Takako Eguchi Nakajima, Kengo Nagashima, et al.
Oncology|June 12, 2008
Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancerJunichi Matsubara, Yasuhide Yamada, Takako E Nakajima, et al.
Japanese Journal of Clinical Oncology|April 7, 2011
A Phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical Stage II/III squamous cell carcinoma of anal canal (JCOG0903: SMART-AC)Atsuo Takashima, Yasuhiro Shimada, Tetsuya Hamaguchi, et al.
Pageof 30